SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 149 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.87 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $62,000 | -95.7% | 48,301 | -95.8% | 0.00% | -100.0% |
Q4 2021 | $1,445,000 | -43.9% | 1,138,160 | -3.6% | 0.00% | -50.0% |
Q3 2021 | $2,575,000 | -41.6% | 1,180,984 | +0.5% | 0.00% | -33.3% |
Q2 2021 | $4,407,000 | +28.7% | 1,175,172 | +11.9% | 0.00% | +50.0% |
Q1 2021 | $3,423,000 | -2.9% | 1,050,078 | +1.6% | 0.00% | -33.3% |
Q4 2020 | $3,526,000 | -19.7% | 1,033,923 | -3.9% | 0.00% | -25.0% |
Q3 2020 | $4,391,000 | +45.2% | 1,076,210 | +20.3% | 0.00% | +33.3% |
Q2 2020 | $3,024,000 | +46.3% | 894,695 | +0.8% | 0.00% | +50.0% |
Q1 2020 | $2,067,000 | -38.5% | 887,329 | -3.9% | 0.00% | -33.3% |
Q4 2019 | $3,360,000 | -56.1% | 923,116 | +0.0% | 0.00% | -57.1% |
Q3 2019 | $7,657,000 | +0.6% | 923,014 | +4.5% | 0.01% | 0.0% |
Q2 2019 | $7,608,000 | -18.9% | 883,603 | +0.7% | 0.01% | -22.2% |
Q1 2019 | $9,380,000 | +25.6% | 877,436 | +2.8% | 0.01% | +12.5% |
Q4 2018 | $7,466,000 | -46.6% | 853,294 | +2.5% | 0.01% | -33.3% |
Q3 2018 | $13,981,000 | -12.1% | 832,214 | +9.6% | 0.01% | -20.0% |
Q2 2018 | $15,909,000 | +37.1% | 759,004 | +5.2% | 0.02% | +36.4% |
Q1 2018 | $11,606,000 | -12.8% | 721,337 | +2.7% | 0.01% | -8.3% |
Q4 2017 | $13,309,000 | +61.4% | 702,317 | +19.8% | 0.01% | +50.0% |
Q3 2017 | $8,247,000 | +100.3% | 586,141 | +6.0% | 0.01% | +100.0% |
Q2 2017 | $4,118,000 | +14.5% | 552,868 | -0.1% | 0.00% | 0.0% |
Q1 2017 | $3,598,000 | +53.5% | 553,451 | +4.6% | 0.00% | +33.3% |
Q4 2016 | $2,344,000 | -4.2% | 529,206 | +1.0% | 0.00% | 0.0% |
Q3 2016 | $2,447,000 | -15.3% | 523,950 | +19.1% | 0.00% | -25.0% |
Q2 2016 | $2,890,000 | +8.8% | 439,980 | +5.3% | 0.00% | 0.0% |
Q1 2016 | $2,657,000 | +9.7% | 417,723 | +4.0% | 0.00% | 0.0% |
Q4 2015 | $2,421,000 | +5.4% | 401,545 | +4.5% | 0.00% | 0.0% |
Q3 2015 | $2,298,000 | -10.8% | 384,219 | +1.9% | 0.00% | 0.0% |
Q2 2015 | $2,577,000 | +12.5% | 376,883 | -0.0% | 0.00% | +33.3% |
Q1 2015 | $2,290,000 | -10.0% | 377,042 | +2.7% | 0.00% | -25.0% |
Q4 2014 | $2,544,000 | -15.4% | 367,114 | -0.7% | 0.00% | -20.0% |
Q3 2014 | $3,008,000 | +3.7% | 369,563 | +3.5% | 0.01% | 0.0% |
Q2 2014 | $2,902,000 | +5.9% | 356,911 | +2.2% | 0.01% | 0.0% |
Q1 2014 | $2,740,000 | -6.3% | 349,377 | +5.7% | 0.01% | 0.0% |
Q4 2013 | $2,924,000 | +13.4% | 330,411 | +7.5% | 0.01% | 0.0% |
Q3 2013 | $2,579,000 | +17.9% | 307,396 | +4.8% | 0.01% | 0.0% |
Q2 2013 | $2,187,000 | – | 293,181 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 6,963,756 | $145,960,000 | 9.42% |
Avoro Capital Advisors LLC | 3,419,818 | $71,679,000 | 2.76% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 300,000 | $6,285,000 | 2.41% |
Cormorant Asset Management, LP | 1,200,000 | $25,152,000 | 1.86% |
Sio Capital Management, LLC | 143,550 | $3,009,000 | 1.66% |
ASHFORD CAPITAL MANAGEMENT INC | 425,702 | $8,923,000 | 1.18% |
PURA VIDA INVESTMENTS, LLC | 130,700 | $2,739,000 | 1.10% |
Sonora Investment Management, LLC | 298,967 | $6,266,000 | 0.97% |
PURA VIDA INVESTMENTS, LLC | 100,000 | $2,096,000 | 0.84% |
J. Goldman & Co LP | 694,338 | $14,553,000 | 0.75% |